Status:
TERMINATED
A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A study to compare pre-operative administration of rofecoxib versus post-operative administration of diclofenac or rofecoxib, respectively, in the treatment of post-operative pain after total knee joi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Males or females at least 18 years of age who have osteoarthritis of the knee and have undergone total knee joint replacement.
Exclusion
Key Trial Info
Start Date :
May 25 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2004
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00140920
Start Date
May 25 2004
End Date
September 27 2004
Last Update
May 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.